Validation of a priori candidate Alzheimer's disease SNPs with brain amyloid-beta deposition release_gialgk7xljaetptqtvsxjuv7ve

by Michael Vacher, Tenielle Porter, Victor L. Villemagne, Lidija Milicic, Madeline Peretti, Christopher Fowler, Ralph Martins, Stephanie Rainey-Smith, David Ames, Colin L. Masters, Christopher C. Rowe, James D. Doecke (+1 others)


The accumulation of brain amyloid β (Aβ) is one of the main pathological hallmarks of Alzheimer's disease (AD). However, the role of brain amyloid deposition in the development of AD and the genetic variants associated with this process remain unclear. In this study, we sought to identify associations between Aβ deposition and an a priori evidence based set of 1610 genetic markers, genotyped from 505 unrelated individuals (258 Aβ+ and 247 Aβ-) enrolled in the Australian Imaging, Biomarker & Lifestyle (AIBL) study. We found statistically significant associations for 6 markers located within intronic regions of 6 genes, including AC103796.1-BDNF, PPP3R1, NGFR, KL, ABCA7 & CALHM1. Although functional studies are required to elucidate the role of these genes in the accumulation of Aβ and their potential implication in AD pathophysiology, our findings are consistent with results obtained in previous GWAS efforts.
In text/plain format

Published in Scientific Reports by Springer Science and Business Media LLC
ISSN-L 2045-2322
Volume 9
Issue 1
Page(s) 17069
Release Date 2019-11-19
Publisher Springer Science and Business Media LLC
Primary Language en (lookup)

Known Files and URLs

application/pdf  1.3 MB
sha1:2a9c19c79bf059d6c61b... (webarchive) (web)
application/pdf  1.2 MB
sha1:ed7c97b2b366037c79eb... (webarchive) (publisher)
Read Full Text
Type  article-journal
Stage   published
Date   2019-11-19
Container Metadata
Open Access Publication
In Keepers Registery
ISSN-L:  2045-2322
Fatcat Entry
Work Entity
grouping other versions (eg, pre-print) and variants of this release
Cite This Release
Fatcat Bits

State is "active". Revision:
As JSON object via API